Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life
Clicks: 397
ID: 266332
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
77.4
/100
397 views
257 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #4 of 9 articles by views in journal of crohn's & colitis
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Crohn's disease is a destructive, inflammatory condition. The recent IMPACT survey showed that it has a major impact on quality of life including fatigue, relationships and employment. Although patients are generally satisfied with healthcare services, improvements are needed in the timeliness of di …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (43 words).
Try re-searching for a better abstract.
| Reference Key |
d2012journalchanging
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hommes D;Colombel JF;Emery P;Greco M;Sandborn WJ;; |
| Journal | journal of crohn's & colitis |
| Year | 2012 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
Remission Induction
Antibodies
severity of illness index
monoclonal / therapeutic use
health surveys
disease progression
attitude to health
patient care planning
quality of life
crohn disease / therapy*
william j sandborn
jean-frédéric colombel
anti-inflammatory agents / therapeutic use
tumor necrosis factor-alpha / antagonists & inhibitors
crohn disease / diagnosis
pmid:22463929
doi:10.1016/s1873-9946(12)60502-9
daniel hommes
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.